eResearchTechnology, Inc. to Present at the UBS Global Life Sciences Conference on September 23rd, 2008

PHILADELPHIA, Sept. 18  /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (eRT), (NASDAQ:ERES), a leading provider of centralized ECG and eClinical technology, ePRO and other services to the pharmaceutical, biotechnology, medical device and related industries, announced today that Dr. Michael J. McKelvey, the Company's President and Chief Executive Officer, and Keith Schneck, the Company's Chief Financial Officer, are scheduled to present at the UBS Global Life Sciences Conference at 3:30 p.m. EDT on September 23rd, 2008 at the Grand Hyatt Park Avenue Hotel in New York, New York.

Interested parties may access the presentation by visiting the Company's corporate website at http://www.ert.com/ or http://www.ibb.ubs.com/.  The webcast will be available via replay for 90 days.

Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com/) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries on a global basis. The company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including but not limited to 2008 financial guidance, involve a number of risks and uncertainties such as the company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the company's financial results can be found in the company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. 

DATASOURCE: eResearchTechnology, Inc.



CONTACT:  Keith Schneck of eResearchTechnology, Inc., [phone]



Web site:  http://www.ert.com/

http://www.ibb.ubs.com/ 

Copyright